kpcczКомплексные проблемы сердечно-сосудистых заболеванийComplex Issues of Cardiovascular Diseases2306-12782587-9537Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”10.17802/2306-1278-2025-14-5-122-138kpccz-1676Research ArticleАНАЛИТИЧЕСКИЙ ОБЗОР. Сердечно-сосудистая хирургияREVIEWS. Cardiovascular surgeryОБЗОР ЭВОЛЮЦИИ КОНСТРУКЦИЙ ТРАНСКАТЕТЕРНЫХ ИМПЛАНТОВ АОРТАЛЬНОГО КЛАПАНАREVIEW OF THE EVOLUTION OF TRANSCATHETER AORTIC VALVE DESIGNShttps://orcid.org/0000-0001-5669-8696МитрофановаКристина СергеевнаMitrofanovaKristina S.

кандидат технических наук инженер-исследователь лаборатории новых биоматериалов отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация

PhD, Research Engineer at the Laboratory of New Biomaterials, Department of Experimental Medicine, Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation

kirmeetzz@mail.ruhttps://orcid.org/0000-0003-3211-1250КлышниковКирилл ЮрьевичKlyshnikovKirill Yu.

кандидат медицинских наук научный сотрудник лаборатории новых биоматериалов отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация

PhD, Researcher at the Laboratory of New Biomaterials, Department of Experimental Medicine, Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation

klyshnikovk@gmail.comhttps://orcid.org/0000-0001-7477-3979ОвчаренкоЕвгений АндреевичOvcharenkoEvgeny A.

кандидат технических наук заведующий лабораторией новых биоматериалов отдела экспериментальной медицины федерального государственного бюджетного научного учреждения «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний», Кемерово, Российская Федерация

PhD, Head of the Laboratory of New Biomaterials, Department of Experimental Medicine, Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Kemerovo, Russian Federation

ovchea@kemcardio.ruФедеральное государственное бюджетное научное учреждение «Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеваний»РоссияFederal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases”Russian Federation202512112025145122138Copyright © Митрофанова К.С., Клышников К.Ю., Овчаренко Е.А., 20252025Митрофанова К.С., Клышников К.Ю., Овчаренко Е.А.Mitrofanova K.S., Klyshnikov K.Y., Ovcharenko E.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.nii-kpssz.com/jour/article/view/1676Основные положения

Основные положения

 

 

Резюме

Резюме

Анализ литературных данных за последние 20 лет о конструкциях транскатетерных протезов клапанов сердца для лечения болезней системы кровообращения и сердечно-сосудистых заболеваниях основан на доступных для авторов источников – научных публикаций, входящих в перечень: Scopus, Web of Science, PubMed, РИНЦ. Исследование тенденций в проектировании и изменений в конструкциях транскатетерных протезов клапанов сердца за последние 20 лет позволило выявить ряд значительных улучшений. Применение кобальт-хромовых и молибдено-рениевых сплавов вместо нержавеющей стали повысило прочностные и эксплуатационные характеристики опорных каркасов баллонорасширяемых протезов. Самораскрывающиеся протезы лучше адаптируются к анатомии пациентов и снижают риск парапротезной утечки благодаря оптимизации радиальных сил и увеличению размеров ячеек. Несмотря на то, что механически расширяемые протезы были отозваны, из-за сложностей с системой доставки, первоначально, устройства обладали уникальным механизмом фиксации и обеспечивали высокую точность установки, а также возможности репозиции и полного извлечения. Совершенствование технологий обработки биоматериала и улучшение геометрии клапанных обшивок снижают риск кальциноза и парапротезных утечек. В совокупности, применяемые конструктивные изменения способствуют улучшению биосовместимости, уменьшают риск кальцификации и в конечном результате повышают надежность и долговечности транскатетерных протезов клапанов сердца.

Highlights

Highlights

 

 

Abstract

Abstract

The analysis of literature data over the past 20 years on the designs of transcatheter prosthetic heart valves for the treatment of cardiovascular diseases is based on sources available to the authors – scientific publications included in the list: Scopus, Web of Science, PubMed, RSCI. The study of trends in the design and changes in the designs of transcatheter prosthetic heart valves over the past 20 years has revealed a number of significant improvements. The use of cobalt-chromium and molybdenum-rhenium alloys instead of stainless steel has increased the strength and performance characteristics of the support frames of balloon-expandable prostheses. Self-expanding prostheses adapt better to the patient's anatomy and reduce the risk of paraprosthetic leakage by optimizing radial forces and increasing cell sizes. Despite the fact that mechanically expandable prostheses were withdrawn due to difficulties with the delivery system, initially, the devices had a unique locking mechanism and provided high installation accuracy, as well as repositioning and complete extraction capabilities. Improving biomaterial processing technologies and improving the geometry of valve linings reduce the risk of calcification and paraprosthetic leaks. Collectively, the applied design changes contribute to improved biocompatibility, reduce the risk of calcification, and ultimately increase the reliability and durability of transcatheter prosthetic heart valves.

Сердечно-сосудистые заболеванияБаллонорасширяемый транскатетерный протез клапана сердцаСамораскрывающийся транскатетерный протез клапана сердцаМеханически расширяемый транскатетерный протез клапана сердцаCardiovascular diseasesBalloon-expandable transcatheter heart valveSelf-expanding transcatheter heart valveMechanically expandable transcatheter heart valveРезультаты получены при поддержке Российской Федерации в лице Министерства науки и высшего образования РФ в рамках Соглашения о предоставлении из федерально-го бюджета грантов в форме субсидий от «30» сентября 2022 г. № 075-15-2022-1202, ком-плексной научно-технической программы полного инновационного цикла «Разработка и внедрение комплекса технологий в областях разведки и добычи твердых полезных иско-паемых, обеспечения промышленной безопасности, биоремедиации, создания новых про-дуктов глубокой переработки из угольного сырья при последовательном снижении эко-логической нагрузки на окружающую среду и рисков для жизни населения» (утвержден-ной распоряжением Правительства Российской Федерации от 11 мая 2022 г. № 1144-р).ReferencesАлекян Б.Г., Григорьян А.М., Стаферов А.В., Карапетян Н.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации - 2021 год. Эндоваскулярная хирургия. 2022; 9: 1–254. doi:10.24183/2409-4080-2022-9SAlekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. X-ray endovascular diagnos-tics and treatment of diseases of the heart and blood vessels in the Russian Federation - 2021. Endovascular surgery. 2022; 9: 1–254. (In Russ)Andersen H.R., Hasenkam J.M., Knudsen L. L. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis. United States patent US5411552A 1995 May 023. Andersen H.R. How Transcatheter Aortic Valve Implantation (TAVI) Was Born: The Struggle for a New Invention. Frontiers in Cardiovascular Medicine. 2021; 8. doi:10.3389/fcvm.2021.722693Andersen H.R., Hasenkam J.M., Knudsen L. L. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis. United States patent US5411552A 1995 May 023. Andersen H.R. How Transcatheter Aortic Valve Implantation (TAVI) Was Born: The Struggle for a New Invention. Frontiers in Cardiovascular Medicine. 2021; 8. doi:10.3389/fcvm.2021.722693Cribier A.G. The Odyssey of TAVR from Concept to Clinical Reality. Texas Heart Institute Journal. 2014; 41(2): 125–130. doi:10.14503/THIJ-14-4137Cribier A.G. The Odyssey of TAVR from Concept to Clinical Reality. Texas Heart Institute Journal. 2014; 41(2): 125–130. doi:10.14503/THIJ-14-4137Ганюков В.И., Тарасов Р.С., Колесников А.Ю., Ганюков И.В. Транскатетерная имплантация аортального клапана: от идеи до внедрения. Комплексные проблемы сердечно-сосудистых заболеваний. 2024; 13(1): 152–164. doi:10.17802/2306-1278-2024-13-1-152-164Ganyukov V.I., Tarasov R.S., Kolesnikov A.Yu., Ganyukov I.V. Transcatheter aortic valve replacement: from idea to implementation. Complex Issues of Cardiovascular Diseases. 2024; 13(1): 152-164. (In Russ)Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis. Circulation. 2002; 106(24): 3006–3008. doi:10.1161/01.CIR.0000047200.36165.B8Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis. Circulation. 2002; 106(24): 3006–3008. doi:10.1161/01.CIR.0000047200.36165.B8Бокерия Л.А., Алексян Б.Г., Пурсанов М.Г., Мироненко В.А. Транскатетерная имплантация аортального клапана : первый опыт в России. Грудная и сердечно-сосудистая хирургия. 2011; (2): 4–11.Bokeria L.A., Aleksyan B.G., Pursanov M.G., Mironenko V.A. Transcatheter aortic valve im-plantation: first experience in Russia. Thoracic and cardiovascular surgery. 2011; (2): 4–11. (In Russ)Billings F.T., Kodali S.K., Shanewise J.S. Transcatheter Aortic Valve Implantation: Anesthetic Considerations. Anesthesia & Analgesia. 2009; 108(5): 1453–1462. doi:10.1213/ane.0b013e31819b07ceBillings F.T., Kodali S.K., Shanewise J.S. Transcatheter Aortic Valve Implantation: Anesthetic Considerations. Anesthesia & Analgesia. 2009; 108(5): 1453–1462. doi:10.1213/ane.0b013e31819b07ceGiannini F., Baldetti L., Gallone G., Tzanis G., Latib A., Colombo A. Transcatheter Valve Replacement in Asia Pacific. Journal of the American College of Cardiology. 2018; 72(24): 3189–3199. doi:10.1016/j.jacc.2018.09.065Giannini F., Baldetti L., Gallone G., Tzanis G., Latib A., Colombo A. Transcatheter Valve Replacement in Asia Pacific. Journal of the American College of Cardiology. 2018; 72(24): 3189–3199. doi:10.1016/j.jacc.2018.09.065Elkoumy A., Jose J., Gunasekaran S., Kumar A., Srinivas B.C., Manjunath C.N., Ravindranath K.S., Parekh M., Chandra P., Kapoor R., Abdelshafy M., Seth A., Agrawal P., Mathur A., Rao R.S., Elzomor H., Sadanada K.S., Kumar V., Arsang-Jang S., et al. Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication. International Journal of Cardiology. 2023; 382: 68–75. doi:10.1016/j.ijcard.2023.04.003Elkoumy A., Jose J., Gunasekaran S., Kumar A., Srinivas B.C., Manjunath C.N., Ravindranath K.S., Parekh M., Chandra P., Kapoor R., Abdelshafy M., Seth A., Agrawal P., Mathur A., Rao R.S., Elzomor H., Sadanada K.S., Kumar V., Arsang-Jang S., et al. Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication. International Journal of Cardiology. 2023; 382: 68–75. doi:10.1016/j.ijcard.2023.04.003Ielasi A., Caminiti R., Pellegrini D., Montonati C., Pellicano M., Giannini F., Briguglia D., De Blasio G., Guagliumi G., Tespili M. Technical Aspects for Transcatheter Aortic Valve Replacement With the Novel Balloon-Expandable Myval Octacor. JACC: Cardiovascular Interventions. 2024; 17(1): 101–103. doi:10.1016/j.jcin.2023.11.011Ielasi A., Caminiti R., Pellegrini D., Montonati C., Pellicano M., Giannini F., Briguglia D., De Blasio G., Guagliumi G., Tespili M. Technical Aspects for Transcatheter Aortic Valve Replacement With the Novel Balloon-Expandable Myval Octacor. JACC: Cardiovascular Interventions. 2024; 17(1): 101–103. doi:10.1016/j.jcin.2023.11.011Базылев В.В., Воеводин А.Б., Раджабов Д.А., Россейкин Е.В. Первый опыт трансапикальной имплантации протеза аортального клапана «МедИнж». Бюллетень НЦССХ им. А.Н. Бакулева РАМН Сердечно-сосудистые заболевания. 2016; 17(6): 141.Bazylev V.V., Voevodin A.B., Radzhabov D.A., Rosseykin E.V. First experience of transapical implantation of the aortic valve prosthesis "MedInzh". Bulletin of the A.N. Bakulev Scientific Center of Cardiovascular Surgery, Russian Academy of Medical Sciences Cardiovascular diseas-es. 2016; 17(6): 141. (In Russ)Богачев-Прокофьев А.В., Шарифулин Р.М., Зубарев Д.Д., Караськов А.М. Первый опыт имплантации транскатетерного протеза аортального клапана «МедЛаб-КТ». Российский кардиологический журнал. 2018; (11): 50–56.BogachevProkofiev A.V., Sharifulin R.M., Zubarev D.D., Karaskov A.M. The first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”. Russian Journal of Cardiology. 2018;(11):50-56. (In Russ)Kodali S.K., Sorajja P., Meduri C.U., Feldt K., Cavalcante J.L., Garg P., Hamid N., Poon K.K., Settergren M.R.M., Burns M.R., Rück A., Sathananthan J., Zajarias A., Shaburishvili T., Zirakashvili T., Zhividze M., Katchakhidze G., Bapat V.N. Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR. EuroIntervention. 2023; 19(4): e352–e362. doi:10.4244/EIJ-D-23-00282Kodali S.K., Sorajja P., Meduri C.U., Feldt K., Cavalcante J.L., Garg P., Hamid N., Poon K.K., Settergren M.R.M., Burns M.R., Rück A., Sathananthan J., Zajarias A., Shaburishvili T., Zirakashvili T., Zhividze M., Katchakhidze G., Bapat V.N. Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR. EuroIntervention. 2023; 19(4): e352–e362. doi:10.4244/EIJ-D-23-00282Akras Z., Sabbak N., Sheng C.C., Yun J., Kapadia S.R. Successful Transseptal Transcatheter Aortic Valve Replacement With Monitored Anesthesia Care and Standard Delivery System. Structural Heart. 2025; 9(2): 100358. doi:10.1016/j.shj.2024.100358Akras Z., Sabbak N., Sheng C.C., Yun J., Kapadia S.R. Successful Transseptal Transcatheter Aortic Valve Replacement With Monitored Anesthesia Care and Standard Delivery System. Structural Heart. 2025; 9(2): 100358. doi:10.1016/j.shj.2024.100358Molchanov A.N., Idov E.M., Kondrashov A.V., Chernyshov S.D., Kardapoltsev L.V., Lipskaja N.A. Historical and Contemporary Clinical Aspects of Transcatheter Aortic Valve Implantation. Journal of Ural Medical Academic Science. 2016; 14(2): 134–146. doi:10.22138/2500-0918-2016-14-2-134-146Molchanov A.N., Idov E.M., Kondrashov A.V., Chernyshov S.D., Kardapoltsev L.V., Lipskaja N.A. Historical and Contemporary Clinical Aspects of Transcatheter Aortic Valve Implantation. Journal of Ural Medical Academic Science. 2016; 14(2): 134–146. doi:10.22138/2500-0918-2016-14-2-134-146Menezes Junior A. da S., Ribeiro M. de F., Laranjeira T. de A., Barbosa V.A., Fernandes J.F. Conduction disorders and permanent cardiac pacemaker after transcatheter aortic implantation - an update overview. International Journal of Research -GRANTHAALAYAH. 2021; 9(8): 14–26. doi:10.29121/granthaalayah.v9.i8.2021.4110Menezes Junior A. da S., Ribeiro M. de F., Laranjeira T. de A., Barbosa V.A., Fernandes J.F. Conduction disorders and permanent cardiac pacemaker after transcatheter aortic implantation - an update overview. International Journal of Research -GRANTHAALAYAH. 2021; 9(8): 14–26. doi:10.29121/granthaalayah.v9.i8.2021.4110Cobey F.C., Ferreira R.G., Naseem T.M., Lessin J., England M., D’Ambra M.N., Shernan S.K., Burkhard Mackensen G., Goldstein S.A., Augoustides J.G. Anesthetic and Perioperative Considerations for Transapical Transcatheter Aortic Valve Replacement. Journal of Cardiothoracic and Vascular Anesthesia. 2014; 28(4): 1075–1087. doi:10.1053/j.jvca.2013.11.006Cobey F.C., Ferreira R.G., Naseem T.M., Lessin J., England M., D’Ambra M.N., Shernan S.K., Burkhard Mackensen G., Goldstein S.A., Augoustides J.G. Anesthetic and Perioperative Considerations for Transapical Transcatheter Aortic Valve Replacement. Journal of Cardiothoracic and Vascular Anesthesia. 2014; 28(4): 1075–1087. doi:10.1053/j.jvca.2013.11.006Solomonica A., Choudhury T., Bagur R. Newer-generation of Edwards transcatheter aortic valve systems: SAPIEN 3, Centera, and SAPIEN 3 Ultra. Expert Review of Medical Devices. 2019; 16(2): 81–87. doi:10.1080/17434440.2019.1555465Solomonica A., Choudhury T., Bagur R. Newer-generation of Edwards transcatheter aortic valve systems: SAPIEN 3, Centera, and SAPIEN 3 Ultra. Expert Review of Medical Devices. 2019; 16(2): 81–87. doi:10.1080/17434440.2019.1555465Tao L., Wang R. Novel Transcatheter Aortic Valve Implantation Devices from Emerging Markets in China. CRC Press; 2024. 5 p.Tao L., Wang R. Novel Transcatheter Aortic Valve Implantation Devices from Emerging Markets in China. CRC Press; 2024. 5 p.Stinis C.T., Abbas A.E., Teirstein P., Makkar R.R., Chung C.J., Iyer V., Généreux P., Kipperman R.M., Harrison J.K., Hughes G.C., Lyons J.M., Rahman A., Kakouros N., Walker J., Roberts D.K., Huang P.-H., Kar B., Dhoble A., Logsdon D.P., et al. Real-World Outcomes for the Fifth-Generation Balloon Expandable Transcatheter Heart Valve in the United States. JACC: Cardiovascular Interventions. 2024; 17(8): 1032–1044. doi:10.1016/j.jcin.2024.02.015Stinis C.T., Abbas A.E., Teirstein P., Makkar R.R., Chung C.J., Iyer V., Généreux P., Kipperman R.M., Harrison J.K., Hughes G.C., Lyons J.M., Rahman A., Kakouros N., Walker J., Roberts D.K., Huang P.-H., Kar B., Dhoble A., Logsdon D.P., et al. Real-World Outcomes for the Fifth-Generation Balloon Expandable Transcatheter Heart Valve in the United States. JACC: Cardiovascular Interventions. 2024; 17(8): 1032–1044. doi:10.1016/j.jcin.2024.02.015Vinayak M., Leone P.P., Tanner R., Dhulipala V., Camaj A., Makhija R.R.K., Hooda A., Kini A.S., Sharma S.K., Khera S. Transcatheter Aortic Valve Replacement: Current Status and Future Indications. Journal of Clinical Medicine. 2024; 13(2): 373. doi:10.3390/jcm13020373Vinayak M., Leone P.P., Tanner R., Dhulipala V., Camaj A., Makhija R.R.K., Hooda A., Kini A.S., Sharma S.K., Khera S. Transcatheter Aortic Valve Replacement: Current Status and Future Indications. Journal of Clinical Medicine. 2024; 13(2): 373. doi:10.3390/jcm13020373Grube E., Laborde J.C., Gerckens U., Felderhoff T., Sauren B., Buellesfeld L., Mueller R., Menichelli M., Schmidt T., Zickmann B., Iversen S., Stone G.W. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease. Circulation. 2006; 114(15): 1616–1624. doi:10.1161/CIRCULATIONAHA.106.639450Grube E., Laborde J.C., Gerckens U., Felderhoff T., Sauren B., Buellesfeld L., Mueller R., Menichelli M., Schmidt T., Zickmann B., Iversen S., Stone G.W. Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease. Circulation. 2006; 114(15): 1616–1624. doi:10.1161/CIRCULATIONAHA.106.639450Kempfert J., Möllmann H., Walther T. Symetis ACURATE TA valve. EuroIntervention. 2012; 8(Q): Q102–Q109. doi:10.4244/EIJV8SQA19Kempfert J., Möllmann H., Walther T. Symetis ACURATE TA valve. EuroIntervention. 2012; 8(Q): Q102–Q109. doi:10.4244/EIJV8SQA19Manoharan G., Spence M., Rodés-Cabau J., Webb J. St Jude Medical Portico valve. EuroIntervention. 2012; 8(Q): Q97–Q101. doi:10.4244/EIJV8SQA18Manoharan G., Spence M., Rodés-Cabau J., Webb J. St Jude Medical Portico valve. EuroIntervention. 2012; 8(Q): Q97–Q101. doi:10.4244/EIJV8SQA18Cheung A., Makkar R., Fontana G.P. St. Jude Medical PorticoTM transapical technology. EuroIntervention. 2013; 9(S): S103–S106. doi:10.4244/EIJV9SSA21Cheung A., Makkar R., Fontana G.P. St. Jude Medical PorticoTM transapical technology. EuroIntervention. 2013; 9(S): S103–S106. doi:10.4244/EIJV9SSA21Reardon M.J. The ACURATE neo TM and neo2 TM Valve Systems. Heart International. 2021; 15(1): 37. doi:10.17925/HI.2021.15.1.37Reardon M.J. The ACURATE neo TM and neo2 TM Valve Systems. Heart International. 2021; 15(1): 37. doi:10.17925/HI.2021.15.1.37Крестьянинов О.В., Баранов А.А., Ибрагимов Р.У., Хелимский Д.А., Бадоян А.Г., Горгулько А.П., Утегенов Р.Б. Непосредственные результаты транскатетерного протезирования аортального клапана: данные одноцентрового регистра. Сибирский журнал клинической и экспериментальной медицины. 2022; 37(2): 49–56. doi:10.29001/2073-8552-2022-37-2-49-56Krestyaninov O.V., Baranov A.A., Ibragimov R.U., Khelimskii D.A., Badoyan A.G., Gorgulko A.P., Utegenov R.B. In-hospital outcomes of transcatheter aortic valve implantation procedure: data of single-center registry. Siberian Journal of Clinical and Experimental Medicine. 2022;37(2):49-56. (In Russ)Chen F., Niu Y., Feng Y., Chen M. First-in-Man Experience of a Fully Retrievable Self-Expanding Dry-Tissue Transcatheter Aortic Valve Replacement System. JACC: Cardiovascular Interventions. 2022; 15(16): 1681–1682. doi:10.1016/j.jcin.2022.05.032Chen F., Niu Y., Feng Y., Chen M. First-in-Man Experience of a Fully Retrievable Self-Expanding Dry-Tissue Transcatheter Aortic Valve Replacement System. JACC: Cardiovascular Interventions. 2022; 15(16): 1681–1682. doi:10.1016/j.jcin.2022.05.032Briedis K., Mizariene V., Rumbinaite E., Jurenas M., Aldujeli A., Briede K., Jakuska P., Jankauskas A., Ceponiene I., Lenkutis T., Zaliunas R., Benetis R. Safety and performance of the Vienna self-expandable transcatheter aortic valve system: 6-month results of the VIVA first-in-human feasibility study. Frontiers in Cardiovascular Medicine. 2023; 10. doi:10.3389/fcvm.2023.1199047Briedis K., Mizariene V., Rumbinaite E., Jurenas M., Aldujeli A., Briede K., Jakuska P., Jankauskas A., Ceponiene I., Lenkutis T., Zaliunas R., Benetis R. Safety and performance of the Vienna self-expandable transcatheter aortic valve system: 6-month results of the VIVA first-in-human feasibility study. Frontiers in Cardiovascular Medicine. 2023; 10. doi:10.3389/fcvm.2023.1199047Liao Y., Zhao Z., Wei X., Xu Y., Zuo Z., Li Y., Zheng M., Feng Y., Chen M. Transcatheter aortic valve implantation with the self‐expandable venus A‐Valve and CoreValve devices: Preliminary Experiences in China. Catheterization and Cardiovascular Interventions. 2017; 89(S1): 528–533. doi:10.1002/ccd.26912Liao Y., Zhao Z., Wei X., Xu Y., Zuo Z., Li Y., Zheng M., Feng Y., Chen M. Transcatheter aortic valve implantation with the self‐expandable venus A‐Valve and CoreValve devices: Preliminary Experiences in China. Catheterization and Cardiovascular Interventions. 2017; 89(S1): 528–533. doi:10.1002/ccd.26912Choudhury T., Solomonica A., Bagur R. The Evolut R and Evolut PRO transcatheter aortic valve systems. Expert Review of Medical Devices. 2019; 16(1): 3–9. doi:10.1080/17434440.2019.1557045Choudhury T., Solomonica A., Bagur R. The Evolut R and Evolut PRO transcatheter aortic valve systems. Expert Review of Medical Devices. 2019; 16(1): 3–9. doi:10.1080/17434440.2019.1557045Wenaweser P., Stortecky S., Schütz T., Praz F., Gloekler S., Windecker S., Elsässer A. Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve. EuroIntervention. 2016; 12(1): 71–77. doi:10.4244/EIJV12I1A13Wenaweser P., Stortecky S., Schütz T., Praz F., Gloekler S., Windecker S., Elsässer A. Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve. EuroIntervention. 2016; 12(1): 71–77. doi:10.4244/EIJV12I1A13Jagielak D., Stanska A., Klapkowski A., Brzezinski M., Kowalik M., Ciecwierz D., Jaguszewski M., Fijalkowski M. Transfermoral aortic valve implantation using self-expanding New Valve Technology (NVT) Allegra bioprosthesis: A pilot prospective study. Cardiology Journal. 2021; 28(3): 384–390. doi:10.5603/CJ.a2019.0019Jagielak D., Stanska A., Klapkowski A., Brzezinski M., Kowalik M., Ciecwierz D., Jaguszewski M., Fijalkowski M. Transfermoral aortic valve implantation using self-expanding New Valve Technology (NVT) Allegra bioprosthesis: A pilot prospective study. Cardiology Journal. 2021; 28(3): 384–390. doi:10.5603/CJ.a2019.0019Zhou D., Pan W., Wang J., Wu Y., Chen M., Modine T., Mylotte D., Piazza N., Ge J. VitaFlowTM transcatheter valve system in the treatment of severe aortic stenosis: One‐year results of a multicenter study. Catheterization and Cardiovascular Interventions. 2020; 95(2): 332–338. doi:10.1002/ccd.28226Zhou D., Pan W., Wang J., Wu Y., Chen M., Modine T., Mylotte D., Piazza N., Ge J. VitaFlowTM transcatheter valve system in the treatment of severe aortic stenosis: One‐year results of a multicenter study. Catheterization and Cardiovascular Interventions. 2020; 95(2): 332–338. doi:10.1002/ccd.28226Wang M., Song G., Chen M., Feng Y., Wang J., Liu X., Zhou S., Fang Z., Han Y., Xu K., Yu B., Xu B., Yang Y., Piazza N., Wu Y., Gao R.-L. Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis. EuroIntervention. 2022; 17(13): 1070–1076. doi:10.4244/EIJ-D-21-00040Wang M., Song G., Chen M., Feng Y., Wang J., Liu X., Zhou S., Fang Z., Han Y., Xu K., Yu B., Xu B., Yang Y., Piazza N., Wu Y., Gao R.-L. Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis. EuroIntervention. 2022; 17(13): 1070–1076. doi:10.4244/EIJ-D-21-00040Hellhammer K., Piayda K., Afzal S., Kleinebrecht L., Makosch M., Hennig I., Quast C., Jung C., Polzin A., Westenfeld R., Kelm M., Zeus T., Veulemans V. The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2018; 11(22): 2314–2322. doi:10.1016/j.jcin.2018.07.023Hellhammer K., Piayda K., Afzal S., Kleinebrecht L., Makosch M., Hennig I., Quast C., Jung C., Polzin A., Westenfeld R., Kelm M., Zeus T., Veulemans V. The Latest Evolution of the Medtronic CoreValve System in the Era of Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2018; 11(22): 2314–2322. doi:10.1016/j.jcin.2018.07.023Tung M., Wang X., Li F., Wang H., Guo Y., Wang C., Wei L., Luo X., Wang X., Wang W. A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. Journal of Cardiology. 2018; 72(5): 377–384. doi:10.1016/j.jjcc.2018.05.020Tung M., Wang X., Li F., Wang H., Guo Y., Wang C., Wei L., Luo X., Wang X., Wang W. A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system. Journal of Cardiology. 2018; 72(5): 377–384. doi:10.1016/j.jjcc.2018.05.020Bhogal S., Rogers T., Merdler I., Reddy P., Ali S., Shea C., Zhang C., Ben-Dor I., Satler L.F., Waksman R. Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement. International Journal of Cardiology. 2023; 389: 131196. doi:10.1016/j.ijcard.2023.131196Bhogal S., Rogers T., Merdler I., Reddy P., Ali S., Shea C., Zhang C., Ben-Dor I., Satler L.F., Waksman R. Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement. International Journal of Cardiology. 2023; 389: 131196. doi:10.1016/j.ijcard.2023.131196Tobe A., Garg S., Möllmann H., Rück A., Kim W.-K., Buono A., Scotti A., Latib A., Toggweiler S., Mangieri A., Laine M., Meduri C.U., Rheude T., Wong I., Pruthvi C.R., Tsai T.-Y., Onuma Y., Serruys P.W. Short-Term Outcomes of ACURATE neo2. Structural Heart. 2024; 8(3): 100277. doi:10.1016/j.shj.2023.100277Tobe A., Garg S., Möllmann H., Rück A., Kim W.-K., Buono A., Scotti A., Latib A., Toggweiler S., Mangieri A., Laine M., Meduri C.U., Rheude T., Wong I., Pruthvi C.R., Tsai T.-Y., Onuma Y., Serruys P.W. Short-Term Outcomes of ACURATE neo2. Structural Heart. 2024; 8(3): 100277. doi:10.1016/j.shj.2023.100277Wong I., Bajoras V., Wang X., Bieliauskas G., De Backer O., Søndergaard L. Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve. JACC: Cardiovascular Interventions. 2021; 14(19): e259–e261. doi:10.1016/j.jcin.2021.06.034Wong I., Bajoras V., Wang X., Bieliauskas G., De Backer O., Søndergaard L. Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve. JACC: Cardiovascular Interventions. 2021; 14(19): e259–e261. doi:10.1016/j.jcin.2021.06.034Aoun J., Zaid S., Goel S., Reardon M.J. A Comprehensive Evaluation of the NAVITOR Transcatheter Aortic Valve Replacement System. Heart International. 2024; 18(1). doi:10.17925/HI.2024.18.1.4Aoun J., Zaid S., Goel S., Reardon M.J. A Comprehensive Evaluation of the NAVITOR Transcatheter Aortic Valve Replacement System. Heart International. 2024; 18(1). doi:10.17925/HI.2024.18.1.4Buono A., Messina A., Bettari L., Pero G., Cuccia C., Ielasi A., Bieliauskas G., Maffeo D. Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement. EuroIntervention. 2022; 18(10): 822–823. doi:10.4244/EIJ-D-22-00173Buono A., Messina A., Bettari L., Pero G., Cuccia C., Ielasi A., Bieliauskas G., Maffeo D. Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement. EuroIntervention. 2022; 18(10): 822–823. doi:10.4244/EIJ-D-22-00173Zaid S., Attizzani G.F., Krishnamoorthy P., Yoon S.-H., Palma Dallan L.A., Chetcuti S., Fukuhara S., Grossman P.M., Goel S.S., Atkins M.D., Kleiman N.S., Puri R., Bakhtadze B., Byrne T., Ibrahim A.W., Grubb K.J., Tully A., Herrmann H.C., Faggioni M., et al. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System. JACC: Cardiovascular Interventions. 2023; 16(13): 1626–1635. doi:10.1016/j.jcin.2023.05.004Zaid S., Attizzani G.F., Krishnamoorthy P., Yoon S.-H., Palma Dallan L.A., Chetcuti S., Fukuhara S., Grossman P.M., Goel S.S., Atkins M.D., Kleiman N.S., Puri R., Bakhtadze B., Byrne T., Ibrahim A.W., Grubb K.J., Tully A., Herrmann H.C., Faggioni M., et al. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System. JACC: Cardiovascular Interventions. 2023; 16(13): 1626–1635. doi:10.1016/j.jcin.2023.05.004Zhang C., Zhang D. Simultaneous TAVR and PBPV in Patient With Multiple Valve Disease. JACC: Case Reports. 2025; 30(4): 102933. doi:10.1016/j.jaccas.2024.102933Zhang C., Zhang D. Simultaneous TAVR and PBPV in Patient With Multiple Valve Disease. JACC: Case Reports. 2025; 30(4): 102933. doi:10.1016/j.jaccas.2024.102933Peijia Medical’s Third-Generation TaurusNXT TAVR Device Studied in China for Regulatory Approval. Режим https://citoday.com/news/peijia-medicals-third-generation-taurusnxt-tavr-device-studied-in-china-for-regulatory-approval (дата обращения 23.06.2013).Peijia Medical’s Third-Generation TaurusNXT TAVR Device Studied in China for Regulatory Approval. Режим https://citoday.com/news/peijia-medicals-third-generation-taurusnxt-tavr-device-studied-in-china-for-regulatory-approval (дата обращения 23.06.2013).Giuliani C., Fernández-Pereira C., González V., Andersen G., Menéndez M., Peralta S., Lazarte J., Tetamanzi A., Grinfeld D., Debrahi J.P., Samaja G., Mieres J., Ascarrunz-Cattoretti D., Haiek C., Sztejfman M. Early experience in Argentina and Latin America with aortic valve transcatheter implantation with the VitaFlow self-expanding transcatheter heart valve. Revista Argentina de Cardioangiología Intervencionista. 2022; 13(3): 130–1355.Giuliani C., Fernández-Pereira C., González V., Andersen G., Menéndez M., Peralta S., Lazarte J., Tetamanzi A., Grinfeld D., Debrahi J.P., Samaja G., Mieres J., Ascarrunz-Cattoretti D., Haiek C., Sztejfman M. Early experience in Argentina and Latin America with aortic valve transcatheter implantation with the VitaFlow self-expanding transcatheter heart valve. Revista Argentina de Cardioangiología Intervencionista. 2022; 13(3): 130–1355.Adam M., Tamm A.R., Wienemann H., Unbehaun A., Klein C., Arnold M., Marwan M., Theiss H., Braun D., Bleiziffer S., Geyer M., Goncharov A., Kuhn E., Falk V., von Bardeleben R.S., Achenbach S., Massberg S., Baldus S., Treede H., et al. Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System. JACC: Cardiovascular Interventions. 2023; 16(16): 1965–1973. doi:10.1016/j.jcin.2023.07.038Adam M., Tamm A.R., Wienemann H., Unbehaun A., Klein C., Arnold M., Marwan M., Theiss H., Braun D., Bleiziffer S., Geyer M., Goncharov A., Kuhn E., Falk V., von Bardeleben R.S., Achenbach S., Massberg S., Baldus S., Treede H., et al. Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System. JACC: Cardiovascular Interventions. 2023; 16(16): 1965–1973. doi:10.1016/j.jcin.2023.07.038Sethi A., Russo M. Novel transcatheter aortic valve replacement devices. JTCVS Structural and Endovascular. 2025; 5: 100040. doi:10.1016/j.xjse.2024.100040Sethi A., Russo M. Novel transcatheter aortic valve replacement devices. JTCVS Structural and Endovascular. 2025; 5: 100040. doi:10.1016/j.xjse.2024.100040Brankovic M., Sharma A. Transcatheter Aortic Valve Implantation and Replacement: The Latest Advances and Prospects. Journal of Clinical Medicine. 2025; 14(6): 1844. doi:10.3390/jcm14061844Brankovic M., Sharma A. Transcatheter Aortic Valve Implantation and Replacement: The Latest Advances and Prospects. Journal of Clinical Medicine. 2025; 14(6): 1844. doi:10.3390/jcm14061844

The authors declare that there are no conflicts of interest present.